Abstract:HIV-1 (Human immunodeficiency virus-1) has been causing severe pandemics by attacking the immune system of its host. Left untreated, it can lead to AIDS (acquired immunodeficiency syndrome), where death is inevitable due to opportunistic diseases. Therefore, discovering new antiviral drugs against HIV-1 is crucial. This study aimed to explore a novel machine learning approach to classify compounds that inhibit HIV-1 integrase and screen the dataset of repurposing compounds. The present study had two main stages: selecting the best type of fingerprint or molecular descriptor using the Wilcoxon signed-rank test and building a computational model based on machine learning. In the first stage, we calculated 16 different types of fingerprint or molecular descriptors from the dataset and used each of them as input features for 10 machine-learning models, which were evaluated through cross-validation. Then, a meta-analysis was performed with the Wilcoxon signed-rank test to select the optimal fingerprint or molecular descriptor types. In the second stage, we constructed a model based on the optimal fingerprint or molecular descriptor type. This data followed the machine learning procedure, including data preprocessing, outlier handling, normalization, feature selection, model selection, external validation, and model optimization. In the end, an XGBoost model and RDK7 fingerprint were identified to be the most suitable. The model achieved promising results, with an average precision of 0.928 ± 0.027 and an F1-score of 0.848 ± 0.041 in cross-validation. The model achieved an average precision of 0.921 and an F1-score of 0.889 in external validation. Molecular docking was performed and validated by redocking for docking power and retrospective control for screening power, with the AUC metrics being 0.876 and the threshold being identified at –9.71 kcal/mol. Finally, 44 compounds from DrugBank repurposing data were selected from the QSAR model, then three candidates were identified as potential compounds from molecular docking, and PSI-697 was detected as the most promising molecule, with in vitro experiment being not performed (docking score: -17.14 kcal/mol, HIV integrase inhibitory probability: 69.81%)

Prediction of HIV-1 protease cleavage site from octapeptide sequence information using selected classifiers and hybrid descriptors

HIV‐1 Protease Cleavage Site Prediction Based on Amino Acid Property

HIV-1 Protease Cleavage Site Prediction Based on Two-Stage Feature Selection Method

A Vector Projection Approach to Predicting Hiv Protease Cleavage Sites in Proteins

The Application of Deep Learning in the Prediction of HIV-1 Protease Cleavage Site

Predicting Human Immunodeficiency Virus Protease Cleavage Sites in Nonlinear Projection Space

Incorporating the Coevolving Information of Substrates in Predicting HIV-1 Protease Cleavage Sites

Prediction of HIV‐1 Protease Inhibitors Using Machine Learning Approaches

In Silico Prediction of Mutant HIV-1 Proteases Cleaving a Target Sequence

HIVcleave: a web-server for predicting human immunodeficiency virus protease cleavage sites in proteins.

An Alternate-Subsite-Coupled Model for Predicting Hiv Protease Cleavage Sites in Proteins

Multiobjective evolutionary-based multi-kernel learner for realizing transfer learning in the prediction of HIV-1 protease cleavage sites

Predicting Anti‐HIV‐1 Activities of HEPT‐analog Compounds by Using Support Vector Classification

Predicting Drug Resistance of the HIV‐1 Protease Using Molecular Interaction Energy Components

Studies on the Prediction of Selective Cleavage Sites and Cleavage Profile of Proteasome Using VHSE Amino Acid Descriptor

Scores of Amino Acid 0D-3D Information As Applied in Cleavage Site Prediction and Better Specificity Elucidation for Human Immunodeficiency Virus Type 1 Protease

Novel machine learning approach toward classification model of HIV-1 integrase inhibitors

Quantitative Prediction of Human Immunodeficiency Virus Drug Resistance

Compositional framework for multitask learning in the identification of cleavage sites of HIV-1 protease

Studies on the Specificity of Hiv Protease - an Application of Markov-Chain Theory

Prediction of HIV Drug Resistance by Combining Sequence and Structural Properties